These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
278 related items for PubMed ID: 29768275
21. Long-term clinical course of anti-glycyl tRNA synthetase (anti-EJ) antibody-related interstitial lung disease pathologically proven by surgical lung biopsy. Sasano H, Hagiwara E, Kitamura H, Enomoto Y, Matsuo N, Baba T, Iso S, Okudela K, Iwasawa T, Sato S, Suzuki Y, Takemura T, Ogura T. BMC Pulm Med; 2016 Dec 01; 16(1):168. PubMed ID: 27903248 [Abstract] [Full Text] [Related]
22. Treatment of antisynthetase-associated interstitial lung disease with tacrolimus. Wilkes MR, Sereika SM, Fertig N, Lucas MR, Oddis CV. Arthritis Rheum; 2005 Aug 01; 52(8):2439-46. PubMed ID: 16052580 [Abstract] [Full Text] [Related]
23. Clinical characteristics of interstitial lung diseases positive to different anti-synthetase antibodies. Jiang M, Dong X, Zheng Y. Medicine (Baltimore); 2021 May 14; 100(19):e25816. PubMed ID: 34106621 [Abstract] [Full Text] [Related]
24. Idiopathic inflammatory myositis-associated interstitial lung disease: ethnicity differences and lung function trends in a British cohort. Chua F, Higton AM, Colebatch AN, O'Reilly K, Grubnic S, Vlahos I, Edwards CJ, Kiely PD. Rheumatology (Oxford); 2012 Oct 14; 51(10):1870-6. PubMed ID: 22763991 [Abstract] [Full Text] [Related]
26. [Clinical and pathological findings of patients with interstitial lung disease associated with antisynthetase]. Hara H, Inoue Y, Sato T. Nihon Kokyuki Gakkai Zasshi; 2005 Nov 14; 43(11):652-63. PubMed ID: 16366363 [Abstract] [Full Text] [Related]
28. Influence of obesity in interstitial lung disease associated with anti-aminoacyl-tRNA synthetase antibodies. Yamaguchi K, Fukushima Y, Yamaguchi A, Itai M, Shin Y, Uno S, Muto S, Kouno S, Tsurumaki H, Yatomi M, Aoki-Saito H, Hara K, Koga Y, Sunaga N, Endo Y, Motegi SI, Nakasatomi M, Sakairi T, Ikeuchi H, Hiromura K, Hisada T, Tsushima Y, Kuwana M, Maeno T. Respir Med; 2022 Mar 14; 193():106741. PubMed ID: 35091206 [Abstract] [Full Text] [Related]
34. The clinical features and prognoses of anti-MDA5 and anti-aminoacyl-tRNA synthetase antibody double-positive dermatomyositis patients. Chen X, Zhang L, Jin Q, Lu X, Lei J, Peng Q, Wang G, Ge Y. Front Immunol; 2022 Mar 14; 13():987841. PubMed ID: 36110863 [Abstract] [Full Text] [Related]
35. Interstitial lung disease with autoantibodies against aminoacyl-tRNA synthetases in the absence of clinically apparent myositis. Friedman AW, Targoff IN, Arnett FC. Semin Arthritis Rheum; 1996 Aug 14; 26(1):459-67. PubMed ID: 8870113 [Abstract] [Full Text] [Related]
38. Pulmonary involvement in long-term mixed connective tissue disease: functional trends and image findings after 10 years. Kawano-Dourado L, Baldi BG, Kay FU, Dias OM, Gripp TE, Gomes PS, Fuller R, Caleiro MT, Kairalla RA, Carvalho CR. Clin Exp Rheumatol; 2015 Aug 14; 33(2):234-40. PubMed ID: 25896472 [Abstract] [Full Text] [Related]
39. [Clinical and radiological features of adult patients with different antisynthetase syndrome based on serum anti-aminoacyl-tRNA synthetase antibody type]. Li S, Huang H, Song XY, Xu K, Wu CY, Wang Q, Xu ZJ. Zhonghua Jie He He Hu Xi Za Zhi; 2017 Dec 12; 40(12):919-924. PubMed ID: 29224302 [Abstract] [Full Text] [Related]